We've found
184,457
clinical trials
We've found
184,457
clinical trials
Neurology Clinical Trial
Updated: 2/9/2016
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling,
Phase
III
Updated: 2/9/2016
Click here to add this to my saved trials

Neurology Clinical Trial
Updated: 2/9/2016
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling,
Phase
III
Updated: 2/9/2016
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Neurology, Psychiatry / Psychology, Other Clinical Trial
Updated: 12/31/1969
Dexamethasone and Postoperative Delirium
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology, Pulmonary / Respiratory Diseases Clinical Trial
Updated: 12/31/1969
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology, Ophthalmology Clinical Trial
Updated: 7/16/2014
Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
Status: Enrolling,
Phase
I, II
Updated: 7/16/2014
Click here to add this to my saved trials

Oncology, Ophthalmology Clinical Trial
Updated: 7/16/2014
Safety and Preliminary Efficacy Study of V404 PDS in Uveitis
Status: Enrolling,
Phase
I, II
Updated: 7/16/2014
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Pulmonary Arterial Hypertension Clinical Trial
Updated: 12/31/1969
OPsumit USers Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease Clinical Trial
Updated: 12/31/1969
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Short Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Registry for Participants With Short Bowel Syndrome
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Aortic Valve Stenosis Clinical Trial
Updated: 12/31/1969
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Aortic Valve Stenosis Clinical Trial
Updated: 12/31/1969
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Multiple Myeloma Clinical Trial
Updated: 5/11/2017
A Study of Pembrolizumab (MK-3475) in Combination With Standard of Care Treatments in Participants With Multiple Myeloma (MK-3475-023/KEYNOTE-023)
Status: Enrolling,
Phase
I
Updated: 5/11/2017
Click here to add this to my saved trials

Alzheimer's Disease Clinical Trial
Updated: 12/17/2015
Computerized Cognition Testing in Participants With Mild Alzheimer's Disease (AD) Treated With Donepezil (MK-0000-318)
Status: Enrolling,
Phase
II
Updated: 12/17/2015
Click here to add this to my saved trials

BIPOLAR DISORDER Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

BIPOLAR DISORDER Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

BIPOLAR DISORDER Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Relapsing Forms of Multiple Sclerosis Clinical Trial
Updated: 12/3/2015
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
Status: Enrolling,
Phase
II
Updated: 12/3/2015
Click here to add this to my saved trials

Type 2 Diabetes Mellitus Clinical Trial
Updated: 3/11/2015
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling,
Phase
III
Updated: 3/11/2015
Click here to add this to my saved trials

Type 2 Diabetes Mellitus Clinical Trial
Updated: 3/11/2015
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling,
Phase
III
Updated: 3/11/2015
Click here to add this to my saved trials

Type 2 Diabetes Mellitus Clinical Trial
Updated: 3/11/2015
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling,
Phase
III
Updated: 3/11/2015
Click here to add this to my saved trials

Type 2 Diabetes Mellitus Clinical Trial
Updated: 3/11/2015
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling,
Phase
III
Updated: 3/11/2015
Click here to add this to my saved trials

Type 2 Diabetes Mellitus Clinical Trial
Updated: 3/11/2015
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling,
Phase
III
Updated: 3/11/2015
Click here to add this to my saved trials

Moderate-severe Pain Clinical Trial
Updated: 12/31/1969
Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Moderate-severe Pain Clinical Trial
Updated: 12/31/1969
Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
Status: Enrolling,
Phase
IV
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Oncology Clinical Trial
Updated: 12/31/1969
Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
